Evidian NewsDesk

Major global pharmaceutical companies have deployed this solution with BIO-key’s biometric identification software

PARIS – Evidian, the European identity and access management leader, today announced that the biometric software of BIO-key International, Inc., a leader in finger-based biometric identification solutions, is now integrated into Evidian’s Enterprise SSO single sign-on solution. Additionally Evidian has successfully deployed this biometric identification solution at two major pharmaceutical companies.

(more…)

PARIS - Evidian, the European identity and access management leader, today announced that its Enterprise SSO solution is compatible with Windows 7 in native 64-bit mode. Enterprise SSO has passed the high standards of compatibility, reliability and performance of Microsoft Corp.’s Windows 7 logo program, ensuring risk-free compatibility with customer infrastructures.

(more…)

PARIS – Evidian today announced a reseller partnership with ManageID, a Dutch systems integrator specializing in identity and access management (IAM). ManageID will provide the Evidian IAM Suite software to its customers in the Netherlands, along with implementation services, training and technical support.

(more…)

Economic crises have always been a pivotal point for company policies. The most recent one is no exception, but in particular it has brought IT security right back at the top of the agenda, so it is once again a central concern for senior management and IT Departments alike. To ensure a healthy and sustainable recovery for its customers, Evidian has reviewed and updated its security offerings, so they are even more transparent, aligned with business needs and deliver even greater added value.

(more…)

PARIS – Evidian, European leader in identity and access management, announced that it has joined the McAfee® Security Innovation Alliance™ Program. As part of participation in this program, Evidian has combined its Enterprise SSO single sign-on solution with McAfee® Endpoint Encryption software.

(more…)